[1] 刘晓洁,李力. 基因多态性与子痫前期[J]. 中国实用妇科与产科杂志,2013,29(10):825-829. [2] Redman CW, Sargent IL. Latest advances in understanding preeclampsia[J]. Science,2005,308: 1592-1594. [3] James JL,Whitley GS,Cartwright JE. Pre-eclampsia: fitting together the placental, immune and cardiovascular pieces[J]. J Pathol,2010, 221: 363-378. [4] Verlohren S,Muller DN,Luft FC,et al. Immunology in hypertension,preeclampsia, and target-organ damage[J]. Hypertension,2009, 54: 439-443. [5] Morgan T, Ward K. New insights into the genetics of preeclampsia[J]. Semin in Perinatol,1999, 23: 14-23. [6] Friend SL, Hosier S,Nelson A,et al. A thymic stromal cell line supports in vitro development of surface IgM+ B cells and produces a novel growth factor affecting B and T lineage cells [J]. Exp Hematol,1994,22(3): 321-328. [7] 杜晓娜,陈铎. 早发及晚发型重度子痫前期胎盘组织中TSLP的表达及与CD4+CD25+调剂性T细胞的相关性研究[D]. 河北医科大学,2014,3. [8] ACOG. Diagnosis and management of preeclampsia and eclampsia[J]. Int J Gynecol Obstet,2002,77: 67-75. [9] Lin QD,Ye TY. Progress and prospect of the genetic study on preeclampsia[J]. Int Obstet Gynecol,2010, 37(6):377-386. [10] Guo PF, Du MR. Thymic stromal lymphopoietin from trophoblasts induces dendritic cell–mediated regulatory TH2 bias in the decidua during early gestation in humans [J]. Blood, 2010, 116:2061-2069. (2015-01-22收稿 2015-04-16修回)